Shinelab Pharma: Poultry Adenovirus Inactivated Vaccine Approved for New Animal Drug Registration

Shineway Biotech Announcement: According to the "Regulations on the Administration of Veterinary Drugs" and the "Measures for the Registration of Veterinary Drugs", after examination and approval by the Ministry of Agriculture and Rural Affairs of the People's Republic of China, the Avian Adenovirus Inactivated Vaccine jointly developed by the company and other units is designated as a new veterinary drug, and the "Certificate of Registration of New Veterinary Drug" has been issued.